|
Population pharmacokinetics of durvalumab and fixed dosing regimens in patients with advanced solid tumors. |
| |
|
|
Stock and Other Ownership Interests - AstraZeneca |
| |
|
|
| |
|
|
Stock and Other Ownership Interests - AstraZeneca; Roche |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - AstraZeneca |
| |
|
|
Stock and Other Ownership Interests - AstraZeneca |
| |
|
|
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb |
| |
|
|
Stock and Other Ownership Interests - AstraZeneca |
| |
|
|
Stock and Other Ownership Interests - AstraZeneca |
Travel, Accommodations, Expenses - AstraZeneca |
| |
|
|
Stock and Other Ownership Interests - AstraZeneca |
| |
|
|
Stock and Other Ownership Interests - AstraZeneca |